MERS-related coronavirus circulating in pangolins exhibits strong fusogenicity in human cells and high sensitivity to fusion inhibitors
Open Access
- 6 August 2025
- journal article
- Published by Elsevier in Cell Reports Medicine
- Vol. 6 (8) , 102277
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2022YFC2604102, 2024YFA1307402)
- National Natural Science Foundation of China (82341036, 82425033, 32471244, 92169112, 82372221)
- Science and Technology Commission of Shanghai Municipality (ZD2021CY001)
- Shanghai Rising-Star Program (23QA1408700)
This publication has 44 references indexed in Scilit:
- Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover riskCell, 2025
- Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronavirusesCell, 2025
- Multiple independent acquisitions of ACE2 usage in MERS-related coronavirusesCell, 2025
- Pellino-1, a therapeutic target for control of SARS-CoV-2 infection and disease severityAntiviral Research, 2024
- A bat MERS-like coronavirus circulates in pangolins and utilizes human DPP4 and host proteases for cell entryCell, 2023
- Pan‐coronavirus fusion inhibitors to combat COVID‐19 and other emerging coronavirus infectious diseasesJournal of Medical Virology, 2022
- Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytiaCell, 2021
- Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathologyEBioMedicine, 2020
- Middle East respiratory syndromeThe Lancet, 2015
- Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26Cell Host & Microbe, 2014